Home | Welcome to Contract Pharma   
Last Updated Saturday, December 20 2014

Print RSS Feed

Search Results for 'AMRI'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Search Results:

AMRI
By Gina Rothe, Manager, Marketing Communications
AMRI's business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API) and Drug Product Manufacturing. DDS provides expertise with diverse chemistry, library design and synthesis, in vitro biology and p… Read More »
Published November 19, 2014
Completes remediation following an environmental deviation Read More »
Published November 7, 2014
Contract revenue up 8% in the quarter Read More »
Published August 5, 2014
Cedarburg business boosts large scale manufacturing revenue Read More »
Published June 2, 2014
Expands commercial manufacturing capabilities for specialty injectables Read More »
Published May 6, 2014
Decline in royalties impacts results Read More »
Published April 16, 2014
Will transition DDS ops to other sites Read More »
Published April 3, 2014
AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a s… Read More »
Published November 5, 2013
Resolves all issues at Burlington facility Read More »
Published February 13, 2013
Aims to improve manufacturing routes for selected APIs Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On